Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


Haematologica, Vol 93, Issue 1, 83-89 doi:10.3324/haematol.11535
Copyright © 2008 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Dasgupta et al. Additional Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dasgupta, S.
Right arrow Articles by Lacroix-Desmazes, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasgupta, S.
Right arrow Articles by Lacroix-Desmazes, S.

Hemostasis

Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation

Suryasarathi Dasgupta1,2,3, Ana Maria Navarrete1,2,3, Sebastien André1,2,3, Bharath Wootla1,2,3, Sandrine Delignat1,2,3, Yohann Repessé1,4, Jagadeesh Bayry1,2,3, Antonino Nicoletti1,2,3, Evgueni L. Saenko5, Roseline d’Oiron6, Marc Jacquemin7, Jean-Marie Saint-Remy7, Srini V. Kaveri1,2,3, Sebastien Lacroix-Desmazes1,2,3,

1 Unité 872, Institut National de la Santé et de la Recherche Médicale, Paris, France
2 Centre de Recherche des Cordeliers, Université Pierre et Marie Curie-Paris 6, Unité Mixte de Recherche-Santé 872, Paris, France
3 Unité Mixte de Recherche-Santé 872, Université Paris Descartes, Paris, France
4 Laboratoire d’Hématologie, Université de Caen, France
5 Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA
6 Hemophilia Center, APHP Bicêtre University Hospital, Le Kremlin-Bicêtre, France and
7 Center for Molecular and Vascular Biology, University of Leuven, Belgium

Correspondence: Sebastien Lacroix-Desmazes, INSERM UMRS 872, Equipe 16, Centre de Recherche des Cordeliers, 15 rue de l’Ecole de Médecine, 75006 Paris, France. E-mail: sebastien.lacroix-des-mazes{at}crc.jussieu.fr

Background: The development of factor VIII (FVIII) inhibitors remains the major hurdle in the clinical management of patients with hemophilia A. FVIII uptake by professional antigen-presenting cells (APC) is the first step involved in initiation of immune responses to FVIII. Studies on FVIII catabolism have highlighted the role played by CD91/LRP as a potential target for increasing FVIII half-life in patients and prolonging treatment efficiency. We investigated the involvement of CD91 in FVIII endocytosis by human dendritic cells (DC), a model of professional APC.

Design and Methods: Immature DC were generated from circulating monocytes from healthy donors. Surface expression of CD91 was assessed by flow cytometry. Uptake of fluoroscein isothiocyanate-conjugated ligands by immature DC was studied in the presence of various blocking agents.

Results: CD91 was expressed on approximately 20% of DC and mediated the internalization of its model ligand, {alpha}2-macroglobulin. DC internalized FVIII and activated a human FVIII-specific T-cell clone in a dose-dependent manner. FVIII uptake by DC and subsequent T-cell activation were not inhibited by receptor-associated protein.

Conclusions: Our results indicate that CD91 and other members of the LDL receptor family are not strongly implicated in FVIII internalization by monocyte-derived DC, and suggest the involvement of alternative divalent ion-dependent endocytic receptors.

Key words: hemophilia, factor VIII, inhibitors, dendritic cells, T-cell clone, CD91/LRP.




This article has been cited by other articles:


Home page
BloodHome page
S. Lacroix-Desmazes, A.-M. Navarrete, S. Andre, J. Bayry, S. V. Kaveri, and S. Dasgupta
Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
Blood, July 15, 2008; 112(2): 240 - 249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2008 by the Ferrata Storti Foundation.